Comparison of insulin lispro mixed with NPH or ultralente insulin twice daily in type 1 patients

被引：0

|

作者：

Reviriego, J

Bolanos, E

机构：

来源：

DIABETES | 1998年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

402

引用

收藏

页码：A103 / A103

页数：1

相关论文

共 50 条

[1] Comparison of the effect of using insulin lispro with ultralente and NPH basal regimens in IDDM patients.
Llewelyn, J
Birkett, M
Boggs, B
Roder, M
Berne, C
Prange, A
[J]. DIABETOLOGIA, 1997, 40 : 1383 - 1383
[2] Mixing insulin lispro and ultralente insulin
Bastyr, EJ
Holcombe, JH
Anderson, JH
Clore, JN
[J]. DIABETES CARE, 1997, 20 (06) : 1047 - 1048
[3] Comparison of HbAlc in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70
Maher Issa
[J]. 中华医学杂志(英文版), 2009, (21) : 2540 - 2546
[4] A comparison between humulin ultralente and humulin NPH insulin in insulin requiring type 2 diabetes
Meneghini, LF
Goldberg, RB
Sosenko, JM
[J]. DIABETES, 1999, 48 : A439 - A439
[5] Repaglinicle/bedtime NPH insulin is comparable to twice-daily NPH insulin
Panelo, A
Wing, JR
[J]. DIABETES CARE, 2005, 28 (07) : 1789 - 1790
[6] Mixing insulin lispro and ultralente insulin - Reply
Bolli, GB
Torlone, E
[J]. DIABETES CARE, 1997, 20 (06) : 1048 - 1048
[7] Comparison of premeal insulin lispro plus bedtime NPH with twice-daily NPH: effects on glycemic control and cardiovascular risk factors in type 2 diabetes
Ceriello, A
Del Prato, S
Bue-Valleskey, J
Beattie, S
Gates, J
Malone, J
[J]. DIABETOLOGIA, 2005, 48 : A313 - A313
[8] Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus
Jeong, In-Kyung
Chung, Choon Hee
Zhou, Zhiguang
Han, Jeong Hee
Duan, Ran
Edralin, Diana M.
Rodriguez, Angel
[J]. JOURNAL OF DIABETES, 2017, 9 (04) : 396 - 404
[9] Premeal insulin lispro plus bedtime NPH or twice daily NPH in patients with type 2 diabetes: Effects on glycemic control and cardiovascular (CV) risk factors
Ceriello, A
Del Prato, S
Buevalleskey, J
Beattie, S
Gates, J
Malone, J
[J]. DIABETES, 2005, 54 : A136 - A136
[10] A double blind randomized controlled trial comparing NPH and ultralente as basal insulin replacement with LisPro insulin.
Zinman, B
Ross, S
Campos, R
Strack, T
[J]. DIABETES, 1997, 46 : 166 - 166

← 1 2 3 4 5 →